{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T16:42:00Z","timestamp":1781196120203,"version":"3.54.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,29]]},"DOI":"10.7759\/cureus.91255","type":"journal-article","created":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T20:32:17Z","timestamp":1756499537000},"source":"Crossref","is-referenced-by-count":2,"title":["Drug-Induced Linear IgA Bullous Dermatosis Emerging After Vancomycin Discontinuation in Renal Impairment: Management Amid Serious Infection"],"prefix":"10.7759","author":[{"given":"Kylie  E","family":"Peake","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eunice Y","family":"Chow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Linear IGA Dermatosis","author":"Bernett CN","year":"2025","unstructured":"Bernett CN, Fong M, Yadlapati S, Rosario-Collazo JA. Linear IGA Dermatosis. StatPearls [Internet], StatPearls Publishing, Treasure Island, FL; 2025."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2011.09.018","article-title":"A critical reappraisal of the current data on drug-induced linear immunoglobulin A bullous dermatosis: a real and separate nosological entity?","volume":"66","author":"Fortuna G","year":"2012","unstructured":"Fortuna G, Salas-Alanis JC, Guidetti E, Marinkovich MP. A critical reappraisal of the current data on drug-induced linear immunoglobulin A bullous dermatosis: a real and separate nosological entity?. J Am Acad Dermatol. 2012, 66:988-94. 10.1016\/j.jaad.2011.09.018","journal-title":"J Am Acad Dermatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.clindermatol.2011.03.008","article-title":"Linear immunoglobulin A bullous dermatosis","volume":"30","author":"Fortuna G","year":"2012","unstructured":"Fortuna G, Marinkovich MP. Linear immunoglobulin A bullous dermatosis. Clin Dermatol. 2012, 30:38-50. 10.1016\/j.clindermatol.2011.03.008","journal-title":"Clin Dermatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.iac.2012.04.004","article-title":"Linear IgA disease: clinical presentation, diagnosis, and pathogenesis","volume":"32","author":"Venning VA","year":"2012","unstructured":"Venning VA. Linear IgA disease: clinical presentation, diagnosis, and pathogenesis. Immunol Allergy Clin North Am. 2012, 32:245-53, vi. 10.1016\/j.iac.2012.04.004","journal-title":"Immunol Allergy Clin North Am"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.abd.2024.03.015","article-title":"Linear IgA bullous dermatosis: 32 years of experience","volume":"100","author":"Atci T","year":"2025","unstructured":"Atci T, Pehlivan Ulutas G, G\u00fcreler Sirkeci E, K\u00fc\u00e7\u00fcko\u011flu R. Linear IgA bullous dermatosis: 32 years of experience. An Bras Dermatol. 2025, 100:277-82. 10.1016\/j.abd.2024.03.015","journal-title":"An Bras Dermatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.36481","article-title":"Management options for linear immunoglobulin A (IgA) bullous dermatosis: a literature review","volume":"15","author":"Khan M","year":"2023","unstructured":"Khan M, Park L, Skopit S. Management options for linear immunoglobulin A (IgA) bullous dermatosis: a literature review. Cureus. 2023, 15:e36481. 10.7759\/cureus.36481","journal-title":"Cureus"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/cup.14305","article-title":"Eosinophil-rich linear IgA bullous dermatosis induced by mRNA COVID-19 booster vaccine","volume":"50","author":"Nahm WJ","year":"2023","unstructured":"Nahm WJ, Juarez M, Wu J, Kim RH. Eosinophil-rich linear IgA bullous dermatosis induced by mRNA COVID-19 booster vaccine. J Cutan Pathol. 2023, 50:24-8. 10.1111\/cup.14305","journal-title":"J Cutan Pathol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.30309","article-title":"Linear immunoglobulin A (IgA) bullous dermatosis mimicking Stevens-Johnson syndrome","volume":"14","author":"Park JS","year":"2022","unstructured":"Park JS, Hamilton CD, Patel S, Lee JB, Hsu S. Linear immunoglobulin A (IgA) bullous dermatosis mimicking Stevens-Johnson syndrome. Cureus. 2022, 14:e30309. 10.7759\/cureus.30309","journal-title":"Cureus"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1159\/000353584","article-title":"Linear IgA bullous disease presenting as toxic epidermal necrolysis: a case report and review of the literature","volume":"227","author":"Kakar R","year":"2013","unstructured":"Kakar R, Paugh H, Jaworsky C. Linear IgA bullous disease presenting as toxic epidermal necrolysis: a case report and review of the literature. Dermatology. 2013, 227:209-13. 10.1159\/000353584","journal-title":"Dermatology"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3390\/medicina57080818","article-title":"Updates in the diagnosis and management of linear IgA disease: a systematic review","volume":"57","author":"Shin L","year":"2021","unstructured":"Shin L, Gardner JT 2nd, Dao H Jr. Updates in the diagnosis and management of linear IgA disease: a systematic review. Medicina (Kaunas). 2021, 57:818. 10.3390\/medicina57080818","journal-title":"Medicina (Kaunas)"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.13827","article-title":"Drug-induced linear immunoglobulin A bullous dermatosis: a French retrospective pharmacovigilance study of 69 cases","volume":"85","author":"Garel B","year":"2019","unstructured":"Garel B, Ingen-Housz-Oro S, Afriat D, et al.. Drug-induced linear immunoglobulin A bullous dermatosis: a French retrospective pharmacovigilance study of 69 cases. Br J Clin Pharmacol. 2019, 85:570-9. 10.1111\/bcp.13827","journal-title":"Br J Clin Pharmacol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-3154","article-title":"Drug-induced linear IgA bullous dermatosis: a case report and review of the literature","volume":"99","author":"Lammer J","year":"2019","unstructured":"Lammer J, Hein R, Roenneberg S, Biedermann T, Volz T. Drug-induced linear IgA bullous dermatosis: a case report and review of the literature. Acta Derm Venereol. 2019, 99:508-15. 10.2340\/00015555-3154","journal-title":"Acta Derm Venereol"},{"key":"ref13","article-title":"Vancomycin","author":"Patel S","year":"2025","unstructured":"Patel S, Preuss CV, Bernice F. Vancomycin. StatPearls [Internet], StatPearls Publishing, Treasure Island, FL; 2025."},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-199901000-00001","article-title":"Clinical, demographic, and immunohistologic features of vancomycin-induced linear IgA bullous disease of the skin. Report of 2 cases and review of the literature","volume":"78","author":"Nousari HC","year":"1999","unstructured":"Nousari HC, Kimyai-Asadi A, Caeiro JP, Anhalt GJ. Clinical, demographic, and immunohistologic features of vancomycin-induced linear IgA bullous disease of the skin. Report of 2 cases and review of the literature. Medicine (Baltimore). 1999, 78:1-8. 10.1097\/00005792-199901000-00001","journal-title":"Medicine (Baltimore)"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1001\/archdermatol.2009.68","article-title":"Localized palmar vancomycin-induced linear IgA bullous dermatosis occurring at supratherapeutic levels","volume":"145","author":"Walsh SN","year":"2009","unstructured":"Walsh SN, Kerchner K, Sang\u00fceza OP. Localized palmar vancomycin-induced linear IgA bullous dermatosis occurring at supratherapeutic levels. Arch Dermatol. 2009, 145:603-4. 10.1001\/archdermatol.2009.68","journal-title":"Arch Dermatol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2006.02069.x","article-title":"Vancomycin-induced linear IgA bullous dermatosis in an immunosuppressed transplant recipient","volume":"21","author":"Eisendle K","year":"2007","unstructured":"Eisendle K, Bonatti H, Sepp N, H\u00f6pfl R. Vancomycin-induced linear IgA bullous dermatosis in an immunosuppressed transplant recipient. J Eur Acad Dermatol Venereol. 2007, 21:996-7. 10.1111\/j.1468-3083.2006.02069.x","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/tid.12990","article-title":"Non-infectious diffuse vesiculobullous rash in a pancreas and renal transplant recipient","volume":"20","author":"Rainey A","year":"2018","unstructured":"Rainey A, Auerbach J, Shah K. Non-infectious diffuse vesiculobullous rash in a pancreas and renal transplant recipient. Transpl Infect Dis. 2018, 20:e12990. 10.1111\/tid.12990","journal-title":"Transpl Infect Dis"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2004.01065.x","article-title":"Linear IgA dermatosis in an immunosuppressed patient after allogenic bone marrow transplantation","volume":"18","author":"Schultewolter T","year":"2004","unstructured":"Schultewolter T, Goos M, Dissemond J. Linear IgA dermatosis in an immunosuppressed patient after allogenic bone marrow transplantation. J Eur Acad Dermatol Venereol. 2004, 18:721-5. 10.1111\/j.1468-3083.2004.01065.x","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref19","doi-asserted-by":"crossref","DOI":"10.1378\/chest.2273418","article-title":"Linear IgA bullous dermatosis in a critically ill patient","volume":"148","author":"Hoskote S","year":"2015","unstructured":"Hoskote S, Zamora A, Miest R, Peters M, Scanlon P. Linear IgA bullous dermatosis in a critically ill patient. Chest. 2015, 148:373A.","journal-title":"Chest"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.49185","article-title":"Drug-induced linear IgA bullous dermatosis in an oncologic patient","volume":"15","author":"Quispe-G\u00e1rate LA","year":"2023","unstructured":"Quispe-G\u00e1rate LA, Espinoza-Escudero RB, Salas-Rivera C, S\u00e1nchez-F\u00e9lix G. Drug-induced linear IgA bullous dermatosis in an oncologic patient. Cureus. 2023, 15:e49185. 10.7759\/cureus.49185","journal-title":"Cureus"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.36849\/JDD.6717","article-title":"A case of successful management of adult-onset linear IgA bullous disease with sulfasalazine during the COVID-19 pandemic","volume":"21","author":"Ashraf S","year":"2022","unstructured":"Ashraf S, Elamin S, Tolland J. A case of successful management of adult-onset linear IgA bullous disease with sulfasalazine during the COVID-19 pandemic. J Drugs Dermatol. 2022, 21:1355-7. 10.36849\/JDD.6717","journal-title":"J Drugs Dermatol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.4081\/dr.2023.9574","article-title":"Rituximab for linear immunoglobulin A bullous dermatosis","volume":"15","author":"Dhillon R","year":"2023","unstructured":"Dhillon R, Park L, Gabros S, Nguyen T, Skopit S. Rituximab for linear immunoglobulin A bullous dermatosis. Dermatol Reports. 2023, 15:9574. 10.4081\/dr.2023.9574","journal-title":"Dermatol Reports"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1409556","article-title":"Case report: dupilumab: a promising treatment option for adult linear IgA bullous dermatosis with severe pruritus","volume":"15","author":"Wang L","year":"2024","unstructured":"Wang L, Peng J, Chen J. Case report: dupilumab: a promising treatment option for adult linear IgA bullous dermatosis with severe pruritus. Front Immunol. 2024, 15:1409556. 10.3389\/fimmu.2024.1409556","journal-title":"Front Immunol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2025.1521697","article-title":"Linear IgA bullous dermatosis secondary to drugs: a real-world pharmacovigilance study of the FDA adverse event reporting system","volume":"12","author":"Yang Y","year":"2025","unstructured":"Yang Y, Xie H, Liu S, Jia Y, Cui B, Xiao Z. Linear IgA bullous dermatosis secondary to drugs: a real-world pharmacovigilance study of the FDA adverse event reporting system. Front Med (Lausanne). 2025, 12:1521697. 10.3389\/fmed.2025.1521697","journal-title":"Front Med (Lausanne)"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1111\/hdi.12786","article-title":"Skin lesions and vancomycin use in a hemodialysis patient","volume":"23","author":"Schurder J","year":"2019","unstructured":"Schurder J, Morel P, Blanc J, Clert\u00e9 M, Ridel C, Touzot M. Skin lesions and vancomycin use in a hemodialysis patient. Hemodial Int. 2019, 23:E127-9. 10.1111\/hdi.12786","journal-title":"Hemodial Int"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1177\/106002809703101003","article-title":"Removal of vancomycin during plasmapheresis","volume":"31","author":"McClellan SD","year":"1997","unstructured":"McClellan SD, Whitaker CH, Friedberg RC. Removal of vancomycin during plasmapheresis. Ann Pharmacother. 1997, 31:1132-6. 10.1177\/106002809703101003","journal-title":"Ann Pharmacother"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/s0190-9622(00)90102-6","article-title":"Drug-induced linear IgA bullous dermatosis after vancomycin discontinuance in a patient with renal insufficiency","volume":"42","author":"Klein PA","year":"2000","unstructured":"Klein PA, Callen JP. Drug-induced linear IgA bullous dermatosis after vancomycin discontinuance in a patient with renal insufficiency. J Am Acad Dermatol. 2000, 42:316-23. 10.1016\/s0190-9622(00)90102-6","journal-title":"J Am Acad Dermatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/353276-drug-induced-linear-iga-bullous-dermatosis-emerging-after-vancomycin-discontinuation-in-renal-impairment-management-amid-serious-infection","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T20:32:18Z","timestamp":1756499538000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/353276-drug-induced-linear-iga-bullous-dermatosis-emerging-after-vancomycin-discontinuation-in-renal-impairment-management-amid-serious-infection"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,29]]},"references-count":27,"URL":"https:\/\/doi.org\/10.7759\/cureus.91255","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8,29]]}}}